Pfizer Shot Cleared for Kids 5 to 11 in Pandemic Milestone (1)

Oct. 29, 2021, 9:23 PM UTC

Pfizer Inc. and BioNTech SE’s Covid-19 vaccine was cleared by U.S. regulators for children ages 5 to 11, a long-awaited pandemic milestone that opens a new phase of the immunization campaign.

The emergency authorization, announced Friday in a statement by the Food and Drug Administration, brings the U.S. a step closer to shots being administered at schools, pediatricians’ offices and pharmacies around the country. The formulation for young kids is one-third the dose of the adult shot.

Pfizer pediatric vaccine
Source: Pfizer

Before youngsters can begin to receive the vaccine, the Centers for Disease Control and Prevention’s immunization advisory committee will also ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.